New asthma drug aims to cut hospital visits in half
NCT ID NCT06323213
Summary
This study is testing whether a new drug called 610 can reduce serious asthma attacks in Chinese adults with severe asthma. About 480 participants will receive either the drug or a placebo for one year to see if it lowers the number of attacks requiring emergency care. The main goal is to see if the drug is safe and can help people breathe easier and stay out of the hospital.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shanghai General Hospital
RECRUITINGShanghai, Shanghai Municipality, China
Conditions
Explore the condition pages connected to this study.